Analyst downgrades: HSY, DNA and GRMN
Posted Apr 11th 2008 11:45AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Hershey Co (HSY), Genentech Inc (DNA), Garmin Ltd (GRMN)
.gif)
MOST NOTEWORTHY: Hershey Foods, Genentech and Garmin were today's noteworthy downgrades:
- Bernstein downgraded Hershey Foods (NYSE: HSY) to Market Perform from Outperform, citing commodity cost pressures & slowing volume growth.
- Thomas Weisel downgraded Genentech (NYSE: DNA) to Market Weight from Overweight after the company reported Q1 results, due to Avastin growth concerns and a lack of meaningful drivers of long-term revenue growth until 2009.
- Oppenheimer cut Garmin (NASDAQ: GRMN) to Perform from Outperform on concerns regarding PND pricing and the company's profitability dynamics.
OTHER DOWNGRADES:
- Blackrock (NYSE: BLK) was downgraded at Goldman to Neutral from Buy and to Market Perform from Outperform at Wachovia.
- Baird downgraded Millennium Pharma (NASDAQ: MLNM) to Neutral from Outperform.
- JP Morgan lowered Total SA (NYSE: TOT) to Neutral from Overweight.
Tags: analyst, blackrock, blk, dna, downgrade, garmin, genentech, grmn, hershey, hsy, inthenews, millennium, mlnm, tot, total
Tax Reform in This Election Year: It's Not Likely
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
